Lubenko A, Contreras M. The incidence of hemolytic disease of the newborn attributable to anti-Wra. Transfusion 1992;32: 87–8.LubenkoAContrerasM. The incidence of hemolytic disease of the newborn attributable to anti-Wra. Transfusion1992;32: 87–8.10.1046/j.1537-2995.1992.32192116442.x1731445Search in Google Scholar
Holman CA. A new rare human blood-group antigen (Wra). Lancet 1953;2:119–20.HolmanCA. A new rare human blood-group antigen (Wra). Lancet1953;2:119–20.10.1016/S0140-6736(53)90058-013070555Search in Google Scholar
Bahri T, de Bruyn K, Leys R, Weerkamp F. Fatal acute hemolytic transfusion reaction due to anti-Wra. Transfus Med Hemother 2018;45:438–41.BahriTde BruynKLeysRWeerkampF. Fatal acute hemolytic transfusion reaction due to anti-Wra. Transfus Med Hemother2018;45:438–41.10.1159/000488863628862530574061Search in Google Scholar
Boctor FN. Overt immediate hemolytic transfusion reaction attributable to anti-Wra. Immunohematology 2008;24:113–5.BoctorFN. Overt immediate hemolytic transfusion reaction attributable to anti-Wra. Immunohematology2008;24:113–5.10.21307/immunohematology-2019-282Search in Google Scholar
Cherian G, Search S, Thomas E, Poole J, Davies SV, Massey E. An acute haemolytic transfusion reaction caused by anti-Wra. Transfus Med 2007;17:312–4.CherianGSearchSThomasEPooleJDaviesSVMasseyE. An acute haemolytic transfusion reaction caused by anti-Wra. Transfus Med2007;17:312–4.10.1111/j.1365-3148.2007.00739.x17680958Search in Google Scholar
Arriaga F, Palau J, Lopez F, et al. Anti-Wra in newborn twins. Transfusion 1991;31:381–2.ArriagaFPalauJLopezFAnti-Wra in newborn twins. Transfusion1991;31:381–2.10.1046/j.1537-2995.1991.31491213311.x2021006Search in Google Scholar
Squires A, Nasef N, Lin Y, et al. Hemolytic disease of the newborn caused by anti-Wright (anti-Wra): case report and review of the literature. Neonatal Netw 2012;31:69–80.SquiresANasefNLinYHemolytic disease of the newborn caused by anti-Wright (anti-Wra): case report and review of the literature. Neonatal Netw2012;31:69–80.10.1891/0730-0832.31.2.6922397791Search in Google Scholar
Bunting-Lewis K, Ebbs A. Transfusion reaction caused by anti-Wra in a unit issued by electronic crossmatch. Transfus Med 2005;15(Suppl1):55.Bunting-LewisKEbbsA. Transfusion reaction caused by anti-Wra in a unit issued by electronic crossmatch. Transfus Med2005;15(Suppl1):55.Search in Google Scholar
Keutgens A, Monfort M, Wagemans D, Van Cauwenberge JR, Gérard C. Clinical case of the month: mild hemolytic disease of the newborn to an anti-Wra antibody [in French]. Rev Med Liege 2012;67:403–6.KeutgensAMonfortMWagemansDVan CauwenbergeJRGérardC. Clinical case of the month: mild hemolytic disease of the newborn to an anti-Wra antibody [in French]. Rev Med Liege2012;67:403–6.Search in Google Scholar
Jørgensen J, Jacobsen L. Erythroblastosis fetalis caused by anti-Wra (Wright). Vox Sang 1974;27:478–9.JørgensenJJacobsenL. Erythroblastosis fetalis caused by anti-Wra (Wright). Vox Sang1974;27:478–9.10.1111/j.1423-0410.1974.tb02445.x4420902Search in Google Scholar
Daw E. Haemolytic disease of the newborn due to the Wright antigen. J Obstet Gynaecol Br Commonw 1971;78:377–8.DawE. Haemolytic disease of the newborn due to the Wright antigen. J Obstet Gynaecol Br Commonw1971;78:377–8.10.1111/j.1471-0528.1971.tb00289.x5558323Search in Google Scholar
Metaxas MN, Metaxas-Bühler M. Studies on the Wright blood group system. Vox Sang 1963;8:707–16.MetaxasMNMetaxas-BühlerM. Studies on the Wright blood group system. Vox Sang1963;8:707–16.10.1111/j.1423-0410.1963.tb02377.x14080391Search in Google Scholar
Wallis JP, Hedley GP, Charlton D, Parker PC, Scott Y, Chapman CE. The incidence of anti-Wra and Wra antigen in blood donors and hospital patients. Transfus Med 1996;6:361–4.WallisJPHedleyGPCharltonDParkerPCScottYChapmanCE. The incidence of anti-Wra and Wra antigen in blood donors and hospital patients. Transfus Med1996;6:361–4.10.1111/j.1365-3148.1996.tb00096.x8981731Search in Google Scholar
Garratty G. How concerned should we be about missing antibodies to low incidence antigens? Transfusion 2003;43: 844–7.GarrattyG. How concerned should we be about missing antibodies to low incidence antigens?Transfusion2003;43: 844–7.10.1046/j.1537-2995.2003.00492.x12823741Search in Google Scholar
Coluzzi S, De Nicolò MC, Quattrocchi L, Neri A, Ferruzzi I, Girelli G. Should pre-transfusion screening RBC panels contain Wr(a+) cells? Transfus Med 2010;20:337–40.ColuzziSDe NicolòMCQuattrocchiLNeriAFerruzziIGirelliG. Should pre-transfusion screening RBC panels contain Wr(a+) cells?Transfus Med2010;20:337–40.10.1111/j.1365-3148.2010.01005.x20409071Search in Google Scholar
Kornstad L. Some observations on the Wright blood group system. Vox Sang 1961;6:129–35.KornstadL. Some observations on the Wright blood group system. Vox Sang1961;6:129–35.10.1111/j.1423-0410.1961.tb03146.x13753224Search in Google Scholar
Arriaga F, Llopis F, de la Rubia J, Carpio N, Moscardó J, Marty ML. Incidence of Wra antigen and anti-Wra in a Spanish population. Immunohematology 2005;45:1324–6.ArriagaFLlopisFde la RubiaJCarpioNMoscardóJMartyML. Incidence of Wra antigen and anti-Wra in a Spanish population. Immunohematology2005;45:1324–6.Search in Google Scholar
Muniz JG, Arnoni CP, Gazito D, et al. Frequency of Wra antigen and anti-Wra in Brazilian blood donors. Rev Bras Hematol Hemoter 2015;37:316–9.MunizJGArnoniCPGazitoDFrequency of Wra antigen and anti-Wra in Brazilian blood donors. Rev Bras Hematol Hemoter2015;37:316–9.10.1016/j.bjhh.2015.07.002468509026408365Search in Google Scholar
Greendyke RM, Banzhaf JC. Occurrence of anti-Wra in blood donors and in selected patient groups, with a note on the incidence of the Wra antigen. Transfusion 1977;17:621–4.GreendykeRMBanzhafJC. Occurrence of anti-Wra in blood donors and in selected patient groups, with a note on the incidence of the Wra antigen. Transfusion1977;17:621–4.10.1046/j.1537-2995.1977.17678075661.x595118Search in Google Scholar
Liotta I, Purpura M, Dawes BJ, Giles CM. Some data on the low frequency antigens Wra and BPa. Vox Sang 1970;19:540–3.LiottaIPurpuraMDawesBJGilesCM. Some data on the low frequency antigens Wra and BPa. Vox Sang1970;19:540–3.Search in Google Scholar
Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.IssittPDAnsteeDJ. Applied blood group serology. 4th ed.Durham, NC: Montgomery Scientific Publications, 1998.Search in Google Scholar
Coghlan G. Antibodies to low-incidence antigens. Transfus Apher Sci 2009;40:199–202.CoghlanG. Antibodies to low-incidence antigens. Transfus Apher Sci2009;40:199–202.10.1016/j.transci.2009.03.01319410516Search in Google Scholar
Hoffmann JJML. Anti-Wra: to screen or not to screen? Transfusion 2007;47:948–9.HoffmannJJML. Anti-Wra: to screen or not to screen?Transfusion2007;47:948–9.10.1111/j.1537-2995.2007.01216.x17465965Search in Google Scholar
Schonewille H, van Zijl AM, Wijermans PW. The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matching. Transfusion 2003;43: 939–41.SchonewilleHvan ZijlAMWijermansPW. The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matching. Transfusion2003;43: 939–41.10.1046/j.1537-2995.2003.t01-1-00435.x12823754Search in Google Scholar
Bolton-Maggs PHB. SHOT conference report 2016: serious hazards of transfusion: human factors continue to cause most transfusion-related incidents. Transfus Med 2016;26:401–5.Bolton-MaggsPHB. SHOT conference report 2016: serious hazards of transfusion: human factors continue to cause most transfusion-related incidents. Transfus Med2016;26:401–5.10.1111/tme.1238027995700Search in Google Scholar
Serious hazards of transfusion, SHOT. Report, summary and supplement 2017. Available from /https://www.shotuk.org/shot-reports/report-summary-and-supplement-2017/. Accessed August 2020.Serious hazards of transfusion, SHOT. Report, summary and supplement 2017. Available from /https://www.shotuk.org/shot-reports/report-summary-and-supplement-2017/. Accessed August 2020.Search in Google Scholar
Serious hazards of transfusion, SHOT. Report, summary and supplement 2019. Available from https://www.shotuk.org/shot-reports/report-summary-and-supplement-2019/. https://www.shotuk.org/shot-reports/report-summary-and-supplement-2017/. Accessed August 2020.Serious hazards of transfusion, SHOT. Report, summary and supplement 2019. Available fromhttps://www.shotuk.org/shot-reports/report-summary-and-supplement-2019/. https://www.shotuk.org/shot-reports/report-summary-and-supplement-2017/. Accessed August 2020.Search in Google Scholar
Norsk hemovigilans, Troll. Rapport: overvåking av blod i Norge [Report: blood monitoring in Norway]. Available from https://www.helsedirektoratet.no/rapporter/overvaking-av-blod-i-norge. Accessed August 2020.Norsk hemovigilans, Troll. Rapport: overvåking av blod i Norge [Report: blood monitoring in Norway]. Available fromhttps://www.helsedirektoratet.no/rapporter/overvaking-av-blod-i-norge. Accessed August 2020.Search in Google Scholar